ESG

Amid severe labor shortages, Rain Bird's compact new zone control solution promises to slash installation time and boost water efficiency for contractors.

A new partnership between Vida Health and RxSaveCard offers employers a way to subsidize pricey weight-loss drugs outside of traditional insurance plans.

A clinical trial for D-Serine begins in Norway, testing a novel approach that could finally slow or halt the progression of Parkinson's disease.

The investment firm diversifies from equities into regenerative organic U.S. farmland, using AI to boost yields and create a resilient new asset class.

As Argentina's mining climate improves, a partner-funded drill program at the Cerro Bayo project is set to test high-priority gold-silver targets.

A breakthrough liquid biopsy using '6-base genome' analysis shows unprecedented success in spotting Stage I colorectal cancer, promising to boost survival rates.

The global CRO is acquiring specialized firm Catalyst Clinical Research, aiming to dominate the booming oncology trial market. But can it navigate the risks?

With backing from Joe Burrow and Left Lane Capital, Ultra is tapping into the 'Zyndemic' with a clean, science-backed alternative for guilt-free focus.

For 10 years, McKesson's QCDR has helped oncologists navigate MIPS. Now, new measures aim to elevate patient care and prove the value of treatment.

Budget carrier Avelo Airlines extends its Central Florida schedule through summer 2026, offering low fares and doubling down on its regional strategy.

Aramark's new student-designed 'Gathering Place' moves beyond meals, creating campus hubs for community, wellness, and connection to meet Gen Z's needs.

Chinese brand Kailas FUGA's major partnership with Spain's iconic Penyagolosa Trails signals a strategic shift in the European trail running landscape.

The newly launched Cord Blood Council tackles financial and operational hurdles to strengthen a vital life-saving resource for transplants and future therapies.

Novavax lands a major partnership with Pfizer for its Matrix-M adjuvant, a deal that provides a crucial financial boost and validates its pivot to a tech provider.

As home energy costs continue to climb, proactive HVAC upgrades offer a powerful solution. Learn which improvements provide the biggest savings.

Ascletis Pharma unveils ASC37, a next-gen, once-monthly obesity drug claiming superior potency and convenience, challenging giants like Eli Lilly.

A pioneering project in Maharashtra is empowering women and local communities to lead climate action, offering a replicable new model for the Global South.

Private equity giant G Square is acquiring Finnish firm Serres, signaling a major shift towards sustainable solutions in the modern operating room.

Enparadigm's new AI platform, Catalyx Go, offers a virtual space for professionals to practice high-stakes conversations before they happen.

A federal ban on selling nicotine pouches in convenience stores was meant to protect youth, but critics say it's fueling a dangerous, illegal market.